Assanelli Deodato, Ermolao Andrea, Carre François, Deligiannis Asterios, Mellwig Klaus, Mellwig Klaus, Tahmi Mohamed, Cesana Bruno Mario, Levaggi Rosella, Aliverti Paola, Sharma Sanjay
Intern Emerg Med. 2014 Jun;9(4):427-34. doi: 10.1007/s11739-013-0955-5. Epub 2013 May 26.
Most of the available data on the cardiovascular screening of athletes come from Italy, with fewer records being available outside of Italy and for non-Caucasian populations. The goals of the SMILE project (Sport Medicine Intervention to save Lives through ECG) are to evaluate the usefulness of 12-lead ECGs for the detection of cardiac diseases in athletes from three European countries and one African country and to estimate how many second-level examinations are needed subsequent to the initial screening in order to classify athletes with abnormal characteristics. A digital network consisting of Sport Centres and second and third opinion centres was set up in Greece, Germany, France and Algeria. Standard digital data input was carried out through the application of 12-lead ECGs, Bethesda questionnaires and physical examinations. Two hundred ninety-three of the 6,634 consecutive athletes required further evaluation, mostly (88.4 %) as a consequence of abnormal ECGs. After careful evaluation, 237 were determined to be healthy or apparently healthy, while 56 athletes were found to have cardiac disorders and were thus disqualified from active participation in sports. There was a large difference in the prevalence of diseases detected in Europe as compared with Algeria (0.23 and 4.01 %, respectively). Our data confirmed the noteworthy value of 12-lead resting ECGs as compared with other first-level evaluations, especially in athletes with asymptomatic cardiac diseases. Its value seems to have been even higher in Algeria than in the European countries. The establishment of a digital network of Sport Centres for second/third opinions in conjunction with the use of standard digital data input seems to be a valuable means for increasing the effectiveness of screening.
关于运动员心血管筛查的现有数据大多来自意大利,意大利以外地区以及非白种人群的相关记录较少。SMILE项目(通过心电图拯救生命的运动医学干预)的目标是评估12导联心电图对来自三个欧洲国家和一个非洲国家的运动员心脏疾病检测的有效性,并估计在初始筛查后需要进行多少次二级检查,以便对具有异常特征的运动员进行分类。在希腊、德国、法国和阿尔及利亚建立了一个由体育中心以及二级和三级诊断中心组成的数字网络。通过应用12导联心电图、贝塞斯达问卷和体格检查进行标准数字数据输入。在6634名连续的运动员中,有293人需要进一步评估,其中大部分(88.4%)是由于心电图异常。经过仔细评估,237人被确定为健康或看似健康,而56名运动员被发现患有心脏疾病,因此被取消了积极参与体育运动的资格。与阿尔及利亚相比,欧洲检测出的疾病患病率存在很大差异(分别为0.23%和4.01%)。我们的数据证实了与其他一级评估相比,12导联静息心电图具有显著价值,尤其是对于无症状心脏疾病的运动员。其价值在阿尔及利亚似乎比在欧洲国家更高。建立体育中心二级/三级诊断数字网络并结合使用标准数字数据输入似乎是提高筛查有效性的一种有价值的手段。